Literature DB >> 6430775

Enhancement by secretin of the apparently maximal hepatic transport of bilirubin in the rat.

G L Ricci, R Michiels, J Fevery, J De Groote.   

Abstract

The effect of secretin (0.4 C.U. per hr per 100 gm body weight) on bile flow and the apparent maximal hepatic transport of bilirubin (Tm) was investigated in the rat. When secretin was administered during an already established bilirubin-Tm condition, it increased bile flow and bilirubin-Tm by 15 to 20% over a 30- to 50-min period. Enhancement of bilirubin output correlated with augmented flow and was sustained by an increased rate of excretion of monoglucuronides. When secretin was given for 90 min before bilirubin loading, it enhanced biliary bilirubin concentration and output, largely as diglucuronides. Bilirubin-Tm correlated positively with glururonyltransferase activity in liver homogenates. In the isolated perfused rat liver, injection of secretin in the portal cannula failed to produce choleresis. Bilirubin uridine diphosphate-glucuronyltransferase activity was lower than in intact rats and higher after treatment than in controls. The effect of secretin had an early effect on hepatocytic bile flow and a later effect on conjugation. Maximal hepatic bilirubin output was modulated both by flow and conjugation rate; the two mechanism may act independently.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6430775     DOI: 10.1002/hep.1840040414

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  4 in total

1.  Somatostatin inhibits the effect of secretin on bile flow and on hepatic bilirubin transport in the rat.

Authors:  G L Ricci; J Fevery
Journal:  Gut       Date:  1989-09       Impact factor: 23.059

2.  Biliary excretion and choleretic effect of cefmetazole in rats.

Authors:  J Gonzalez; C Fernandez; E Marińo; A Morales; R Jimenez
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

3.  Effects of secretin on bile production in two kinds of cholestatic models by choledocho-caval fistula and bile duct ligation in rats.

Authors:  Y Fukumoto; M Ando; M Yasunaga; M Okuda; K Okita
Journal:  Gastroenterol Jpn       Date:  1992-06

4.  A new therapeutic trial of secretin in the treatment of intrahepatic cholestasis.

Authors:  Y Fukumoto; K Okita; M Yasunaga; T Konishi; T Yamasaki; M Ando; H Shirasawa; T Fuji; T Takemoto
Journal:  Gastroenterol Jpn       Date:  1989-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.